Expanding Care Networks: Advancing Access and Awareness in the South American Parkinson’s Disease Market

The South American Parkinson’s disease market is experiencing steady growth, driven by rising disease awareness, expanding healthcare coverage, and gradual improvements in neurology-focused infrastructure. Countries such as Brazil, Argentina, and Chile are witnessing increased diagnosis rates as awareness programs and healthcare outreach initiatives expand across urban and semi-urban populations. The region’s market growth is further supported by the entry of global pharmaceutical players introducing innovative oral formulations, extended-release drugs, and non-invasive delivery systems. Although limited access to specialized care and high treatment costs remain challenges, ongoing government health reforms and collaborations with international research organizations are fostering gradual improvements in care quality and accessibility. South America is steadily transitioning toward more structured and patient-centric Parkinson’s disease management.

Key Market Findings

• Rising Awareness and Improved Diagnostic Reach

Increased public health campaigns and medical education programs have significantly improved awareness and diagnosis of Parkinson’s disease across South America. Brazil accounts for the largest patient base in the region, with estimates suggesting over 250,000 diagnosed cases. Efforts by neurological associations and advocacy groups are helping to reduce stigma and encourage early consultation and treatment.

• Expanding Access to Branded and Generic Therapies

The regional market is gradually transitioning from basic levodopa therapies to advanced dopaminergic formulations, including MAO-B inhibitors and extended-release drugs. Multinational pharmaceutical companies such as AbbVie, GSK, and Teva are expanding their presence in key South American markets through partnerships and distribution agreements. Meanwhile, local manufacturers are producing cost-effective generics, increasing treatment accessibility for middle-income populations.

• Government Healthcare Initiatives Supporting Neurocare

Several South American governments are enhancing public healthcare funding for chronic neurological diseases, including Parkinson’s. Brazil’s Unified Health System (SUS) and Argentina’s national health programs are integrating Parkinson’s treatments into public coverage frameworks, ensuring better access to essential medications and follow-up care. These policy shifts are helping bridge treatment gaps across socioeconomic groups.

Companies Covered

Novartis AG, AbbVie Inc., Acadia Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc (GSK), and emerging players/startups. (LIST NOT EXHAUSTIVE)

1. South America Market Methodology and Scope

2. South America Market Definition and Overview

3. South America Market Executive Summary

4. South America Market Dynamics

   1. Market Drivers
   2. Market Restraints
   3. Emerging Opportunities

5. South America Market Industry Analysis

   1. Porter's Five Forces Analysis
   2. Regulatory Analysis
   3. SWOT Analysis
   4. Sustainability Analysis
   5. Unmet Needs and Gaps
   6. Pricing Analysis and Price Dynamics
   7. Latest Developments and Breakthroughs

6. Market Segmentation – By Drug Class

   1. Dopamine Agonists
   2. MAO-B Inhibitors
   3. COMT Inhibitors
   4. Adenosine A2A Receptor Antagonists
   5. Amantadine & Derivatives
   6. Anticholinergics
   7. Others

7. Market Segmentation – By Route of Administration

   1. Oral
   2. Injectable
   3. Others

8. Market Segmentation – By Distribution Channel

   1. Hospital Pharmacies
   2. Retail Pharmacies
   3. Online Pharmacies

9. Market Segmentation – South America

   1. Brazil
   2. Argentina
   3. Rest of South America

10. Competitive Landscape

    1. Competitive Overview and Key Market Players
    2. Market Share Analysis and Positioning Matrix
    3. Strategic Partnerships, Mergers & Acquisitions
    4. Key Developments in Product Portfolios and Innovations
    5. Company Benchmarking

11. Company Profiles

12. Appendix

    1. About Us and Services
    2. Contact Us